Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 10:32 PM
Study NCT ID:
NCT06135558
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2023-11-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Clinical Significance of Marginal Acute Inflammation for Stage II Colon Cancer
Sponsor:
Sun Yat-sen University
Organization:
Study Overview
Official Title:
Presence and Clinical Significance of Marginal Acute Inflammation for Stage II Colon Cancer
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Marginal acute inflammation would make reporting the serosal involvement of tumors controversial. We aimed to investigate the clinical significance and explore the prognostic value of MAI for stage II localized colon cancer.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: